
COVID patients on SSRI antidepressants are less likely to die, study finds
A large analysis of health records from 87 health care centers across the United States found that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), particularly fluoxetine, were significantly less likely to die of COVID-19 than a matched control group. The results add to a body of evidence indicating that SSRIs may have beneficial effects against […]
Read more